Search Results
Results found for "assay development"
- Dr. Steven Foord | Dr. GPCR Ecosystem
He also discovered and championed a novel prostaglandin EP4 drug candidate for development.
- Dr. Nicolas Gilles | Dr. GPCR Ecosystem
properties of these new ligands are deemed exceptional, a lead optimization is realized and its therapeutic development
- Robert Laprairie | Dr. GPCR Ecosystem
Robert Laprairie is an Associate Professor and the Saskatchewan Research Chair in Drug Discovery and Development
- GPCR Weekly News | Dr. GPCR Ecosystem
affinity experiments are interpreted—and how those interpretations quietly shape SAR, lead selection, and development Every week, our team curates the most important developments so you never miss a breakthrough, opportunity
- Dr. Claudia Stäubert | Dr. GPCR Ecosystem
They also explored the possibility of developing an ecosystem for the GPCR University. Developing a Research Ecosystem at GPCR University Yamina and Claudia discussed developing an ecosystem
- Empowering Drug Discovery for the GPCR Community with Dr. Justin English | Dr. GPCR Ecosystem
His lab focuses on developing and innovating technologies to solve broad questions in pharmacology, with
- Dr. J. Silvio Gutkind | Dr. GPCR Ecosystem
A large component of his work is centered around dysregulated signaling in cancer and the development
- G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies
information on dysregulated signaling circuitries and individual genomic and molecular alterations to develop
- Dr. Antonella Di Pizio | Dr. GPCR Ecosystem
medicinal chemist in Italy, followed by a Ph.D. in computational medicinal chemistry, during which she developed
- Dr. Neil Grimsey | Dr. GPCR Ecosystem
We have developed an array of fluorescent biosensors to map kinase activity in living cells and are exploring
- Dr. Josh Pottel | Dr. GPCR Ecosystem
(MFI): a reliable, self-sustaining computational chemistry service provider, developing its own software
- GPCR location matters with Dr. Gabriele Kockelkoren | Dr. GPCR Ecosystem
Alice Ting developing programmable receptors for molecular sensing and controlling cellular behaviour
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
Yekkirala shares the pivotal moments that transformed him from a curious PhD student into a GPCR drug developer scientists interested in translational innovation Biotech investors and strategic leaders seeking new drug development
- irreversible drugs post 2 | Dr. GPCR Ecosystem
Get it wrong, and the best molecule on paper stalls in development.
- GPCRs and the Science Behind Pain and Recovery with Dr. Alex Serafini | Dr. GPCR Ecosystem
Pivoting: Redefining the Pain Research Playbook Looking ahead, Serafini’s vision is bold: build a lab that develops He aspires to become a physician-scientist, with a focus on translational in vitro and in vivo model development Other academic interests of his include studying pharmaceutical finance & healthcare administration and developing
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
She developed expertise over the past two decades studying structure/function relationships of GPCRs
- Dr. Shivani Sachdev | Dr. GPCR Ecosystem
Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors
- Vaithish Velazhahan | Dr. GPCR Ecosystem
He has developed novel tools and methodologies to study fungal GPCRs which allowed the determination
- The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem
She is an internationally recognized biophysicist for her contributions in developing constrained molecular
- Dr. Fiona Marshall | Dr. GPCR Ecosystem
co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development
- Illuminating Functional Selectivity and Allosterism at GPCRs.
He has developed innovative methods for in-cellulo measurement of protein-protein interactions, receptor
- Dr. Brian Arey | Dr. GPCR Ecosystem
Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular
- Dr. Brian Arey | Dr. GPCR Ecosystem
Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular
- Dr. Aaron Sato | Dr. GPCR Ecosystem
Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class
- Dr. Sai Prasad Pydi | Dr. GPCR Ecosystem
Pydi's laboratory is to develop GPCR-based drugs for the treatment of obesity and Type 2 Diabetes (T2D
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
Here’s how we add value: Bridge early discovery to development: transform receptor concepts into validated Learn how to apply GPCR concepts and data to real-world research and development.
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
deciphering of cellular and organ functions, which require individual adhesion GPCRs, and extends to the development
- Dr. Adriano Marchese | Dr. GPCR Ecosystem
The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic development
- Dr. Kevin Pfleger | Dr. GPCR Ecosystem
Professor Pfleger has developed extensive expertise in profiling receptor binding and function at the
- Biochemical Mechanisms Underlying Location Bias in GPCR Signaling
Lefkowitz, where his research focused on biased agonism, with the development of approaches to quantify




























